CANNASWEEP

May 2025


OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business.


If you have any questions or would like more information about any of the items below, please contact us.


We also track cannabis-related legislation introduced in the U.S. Congress.  If you would like to learn more about our Congressional Bill Tracker, please reach out to Ben Dash


Cannabis Rescheduling/Descheduling

  • Trump’s DEA Administrator nominee sidesteps marijuana rescheduling questions

    • Sens. Cory Booker (N.J.) and Alex Padilla (Calif.) asked Cole his position on whether he agrees with a proposal to move cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). In a written response, Cole wrote that he would “give the matter careful consideration after consulting with appropriate personnel within the Drug Enforcement Administration, familiarizing myself with the current status of the regulatory process, and reviewing all relevant information.”

Executive Branch/Enforcement

  • FDA Commissioner identifies psychedelic drug development as a top agency priority in an effort to address unmet needs in mental health.
  • U.S. Justice Dept (DOJ) takes next steps to merge ATF and DEA.
  • The Drug Enforcement Administration (DEA) says that states that have legalized marijuana are providing cover for illicit cultivation operations by foreign cartels—while at the same time implicitly acknowledging that ongoing prohibition in other states creates opportunities for that cannabis to be sold on the illegal market.
  • A report from The National Institute of Standards and Technology (NIST) examines moisture and drying standards in hemp, part of an ongoing project to help laboratories ensure accuracy and precision when testing cannabis products.
  • U.S. Customs and Border Protection (CBP) Drug Seizures Statistics indicate that US Border Patrol (USBP) and Office of Field Operations (OFO) have seized 102,293 lbs. in FYTD 2025.

U.S. Congress

The States

Cannabis Abroad

  • What Europe Can Learn From Cannabis Legalization In North America (Op-Ed).
  • UK vs Germany: Medical Cannabis Products & Prices.
  • South Korea: Welfare Ministry reviews medical cannabis criteria to expand patient access in South Korea.
  • Australia: ‘We’ll win sooner or later’: Legalise Cannabis Party has high hopes after surprise election result.
  • Rwanda: Rwanda’s first medical cannabis production facility is now 83 percent complete, according to the Rwanda Development Board (RDB), placing the country in a leading position among East African states exploring the controversial yet lucrative industry.
  • Germany: Bavarian Minister of Health Judith Gerlach mentions that the legalization of cannabis is wrong and should be corrected

Business, Banking, Insurance

  • 7 Best Marijuana Stocks and ETFs to Buy in 2025.
  • Conifer Insurance Services launches cannabis select program, a high-capacity insurance solution built for the evolving needs of multi-state operators (MSOs) and larger cannabis businesses nationwide.

Research

  • Compared with the general population or individuals who receive all-cause hospital-based care, those with acute care due to cannabis use may be at an increased risk for incident dementia, according to study results published in JAMA Neurology.
  • Psychedelic substances, particularly when combined with behavioral therapies such as Motivational Enhancement Therapy (MET), show significant promise in reducing alcohol misuse and fostering long-term recovery
  • More than one in 10 older veterans who received treatment in the Veterans Health Administration (VHA) reported use of cannabis in the past 30 days, according to a study published this week in JAMA Network Open. This prevalence was about double that of current prevalence estimates in civilian adults aged 65 or older.
  • Study: Classical psychedelic practitioners in research settings believed that physical touch is an important part of psychedelic therapy.

Other Noteworthy Updates

***


If you are interested in exploring commercial opportunities in the cannabis space, we would be happy to assist you in any of your cannabis law questions, comments, or concerns. Please contact Tish Pahl (tpahl@ofwlaw.com), Kyla Kaplan (kkaplan@ofwlaw.com), Denise Calle (dcalle@ofwlaw.com), and Ben Dash (bdash@ofwlaw.com) for assistance.

More From
CANNASWEEP
CANNASWEEP
CANNASWEEP
CANNASWEEP
CANNASWEEP
CANNASWEEP
CANNASWEEP
CANNASWEEP
Subscribe

Subscribe to receive OFW’s Newsletters.